Shanghai, China

Xiuqi Wu

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Crage Medical Co., Limited. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiuqi Wu. Retrieved from https://idiyas.com/inventor/xiuqi-wu-g59fb3an

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cellular Immunotherapy by Xiuqi Wu

Introduction

Xiuqi Wu is a notable inventor based in Shanghai, China. He has made significant contributions to the field of cellular immunotherapy, particularly in methods for treating tumors. His innovative approach combines immune effector cells with specific treatment agents to enhance therapeutic outcomes for patients suffering from cancer.

Latest Patents

Xiuqi Wu holds a patent for a method that involves the application of an immune effector cell expressing a receptor for recognizing tumor antigens. This method also incorporates a second treatment agent, which is a compound of a specific formula or a pharmaceutically acceptable salt thereof. This patent represents a significant advancement in the treatment of tumors, showcasing Wu's commitment to improving cancer therapies.

Career Highlights

Wu is currently associated with Crage Medical Co., Limited, where he continues to develop innovative solutions in medical technology. His work focuses on enhancing the efficacy of immunotherapy, which is crucial in the fight against cancer. His dedication to research and development has positioned him as a key figure in the medical community.

Collaborations

Xiuqi Wu collaborates with Zonghai Li, a fellow researcher, to further explore advancements in immunotherapy. Their partnership aims to push the boundaries of current treatment methodologies and improve patient outcomes.

Conclusion

Xiuqi Wu's contributions to cellular immunotherapy exemplify the potential of innovative approaches in cancer treatment. His patent and ongoing work at Crage Medical Co., Limited highlight the importance of research in developing effective therapies for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…